|Hosted on behalf of the European Commission|
|EudraCT user manual|
|Tutorials on posting results|
|EU Clinical Trials Register|
|Need Help? Contact us!|
Welcome to the EudraCT public home page
EudraCT (European Union Drug Regulating Authorities Clinical Trials Database) is the European database for all interventional clinical trials on medicinal products authorized in the European Union (EEA) and outside the EU/EEA if they are part of a Paediatric Investigation Plan (PIP) from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC. Protocol and results information on interventional clinical trials are made publicly available through the European Union Clinical Trials Register since September 2011.
In order to navigate through the present website, it is strongly encouraged to refer to the EudraCT user manual.
Sponsors’ representatives are recommended to prepare and post clinical trials results as explained in the Tutorials on posting results webpage.
Requirements to provide results for authorised clinical trials: Joint Letter by the European Commission, EMA and HMA
Dear EudraCT users, Please note there is an issue uploading XML in EudraCT CTA module.
Update - The issue with EudraCT number, CTA & Login for posting results has now been resolved.
EudraCT number, CTA & Login for posting results is currently offline. Our technical team is working on it and we hope to resolve this issue as soon as possible. We apologise for any inconvenience.
Problems have been reported on EudraCT database. These may affect requests for assignment of clinical trials as primary user. They will be solved by the end of today. We apologise for this inconvenience and we kindly ask to re-submit your requests for assignment of clinical trials tomorrow, January 8.
EudraCT statistics for the month of December 2019 are now available here.
Due to the high number of users connected, the EudraCT number, CTA & Login for posting results webpage was offline today for 30 minutes.
The EMA will be closed from 21/12/2019 to 05/01/2020.
Previous news can be found here